FINWIRES · TerminalLIVE
FINWIRES

UBS Adjusts Quest Diagnostics Price Target to $220 From $210, Maintains Neutral Rating

-- Quest Diagnostics (DGX) has an average rating of overweight and mean price target of $223.56, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $203.15, Change: $-1.99, Percent Change: -0.97%

Related Articles